0 Comentários
0 Compartilhamentos
167 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
The Future of Cancer Care: How Oncology Therapeutics Are Advancing Patient OutcomesOncology therapeutics have revolutionized cancer care, offering patients a growing arsenal of innovative treatments that are more effective, better tolerated, and more personalized than ever before. From targeted therapies and immunotherapies to novel drug conjugates and gene therapies, these treatments are transforming the way cancer is managed and improving outcomes for patients worldwide....0 Comentários 0 Compartilhamentos 306 Visualizações 0 Anterior
-
Daratumumab Injection Market: Competitive Landscape, Strategic Collaborations, and the Rise of Subcutaneous FormulationsThe Daratumumab Injection Market is a dynamic and highly competitive sector characterized by intense research and development activities, strategic collaborations, and a relentless pursuit of innovation. As the market is projected to reach USD 7.0 billion by 2035, growing at a CAGR of 10.1%, key players are actively seeking to differentiate themselves through advanced product...0 Comentários 0 Compartilhamentos 751 Visualizações 0 Anterior
-
Epidermal Growth Factor Receptor Inhibitor Market Growth Drivers and Investment OpportunitiesThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior